Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Skin Neoplasms

Skin Neoplasms

Part of Cancer

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Skin Neoplasms

5 trials tracked for Skin Neoplasms: 2 in phase 3 or 4 and 1 with published results. The most-cited published study has 22 citations.

5Trials tracked
2Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 2 Phase 2 2 Other / NA 1
  1. Phase 4 CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial Completed · 22 cited
  2. Phase 4 Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients Completed
  3. Phase 2 Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma Completed
  4. Phase 2 5-fluorouracil Versus Placebo in Periocular Full Thickness Skin Grafts Completed
  5. N/A Safety and Performance Evaluation of the Topical Hemostatic Device (AC5™) Following Excision of Skin Lesions Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
PD-L1 expression shows subtype-specific prognostic value in skin neoplasms, meta-analysis finds
Dermatology Meta-analysis
PD-L1 expression shows subtype-specific prognostic value in skin neoplasms, meta-analysis finds Does a common cancer marker predict survival in skin cancers? It depends
A meta-analysis of 24 observational studies found PD-L1 expression was not significantly associated with overall survival (HR=0.89, 95% CI: …
A common skin cancer marker doesn't predict survival for everyone, but it does for specific types like Merkel cell carcinoma and melanoma.
Apr 6, 2026

Research across Cancer

Related studies from across the Cancer family.

Narrative review discusses ginsenosides for skin conditions including psoriasis and dermatitis with noted evidence gaps
Drug Pipeline Sys. Review
Narrative review discusses ginsenosides for skin conditions including psoriasis and dermatitis with noted evidence gaps Review of ginsenosides for skin conditions shows weak evidence and low absorption
This narrative review examines the use of ginsenosides for various skin conditions, including psoriasis, dermatitis, photoaging, chronic non…
A review of ginsenosides for skin issues like psoriasis and melanoma found the evidence is insufficient and absorption is low.
Frontiers Apr 24, 2026
Meta-analysis identifies germline susceptibility loci for rare cancers including MDS and GIST
Genetics & Precision Medicine Cohort
Meta-analysis identifies germline susceptibility loci for rare cancers including MDS and GIST Genes linked to rare cancers found in large study of over 480,000 people
This meta-analysis of observational cohorts from over 480,000 individuals identified novel germline susceptibility loci for rare cancers.
A huge study of over 480,000 people found new genes that raise the risk of several rare cancers, offering clues for families and doctors.
medRxiv Apr 22, 2026